Open access
Aug 2026
Thirteen year population based registry study of prostate cancer incidence and trend in Shahroud Iran using Joinpoint regression
In conclusion between 2010 and 2022, prostate cancer incidence in Shahroud and Meyami showed no statistically significant change and should not be interpreted as evidence of epidemiological stability given the limited statistical power and the absence of systematic PSA screening in Iran.
Abolfazl Emamian, M. Fateh, Zahra Kordi et al.
· Scientific Reports · 0 citations